Controlling loop filtering for interlaced video frames
    1.
    发明申请
    Controlling loop filtering for interlaced video frames 审中-公开
    控制隔行视频帧的环路滤波

    公开(公告)号:US20080084932A1

    公开(公告)日:2008-04-10

    申请号:US11544382

    申请日:2006-10-06

    IPC分类号: H04N11/04 H04B1/66

    摘要: Techniques and tools are described for parameterization, signaling and use of in-loop filtering control information for interlaced video frames in video acceleration. For example, for a macroblock of an interlaced video frame, a decoder parameterizes in-loop filtering decisions as filter control information for video acceleration. The control information indicates filtering control decisions for external edges and internal edges of luma blocks and chroma blocks of the macroblock. The decoder makes the control information available to a video accelerator. The video accelerator retrieves the in-loop filtering control information. For a macroblock of an interlaced video frame, the video accelerator then performs in-loop filtering based at least in part on the control information.

    摘要翻译: 描述技术和工具用于视频加速中的隔行视频帧的参数化,信令和使用环路滤波控制信息。 例如,对于隔行视频帧的宏块,解码器将环路滤波决定参数化为用于视频加速的滤波器控制信息。 控制信息表示对于宏块的亮度块和色度块的外部边缘和内部边缘的滤波控制决定。 解码器使控制信息可用于视频加速器。 视频加速器检索循环过滤控制信息。 对于隔行视频帧的宏块,视频加速器至少部分地基于控制信息来执行循环过滤。

    Techniques to perform fast motion estimation

    公开(公告)号:US08363727B2

    公开(公告)日:2013-01-29

    申请号:US12241662

    申请日:2008-09-30

    申请人: Ce Wang Walid Ali

    发明人: Ce Wang Walid Ali

    IPC分类号: H04N7/12

    摘要: Techniques to perform fast motion estimation are described. An apparatus may comprise a motion estimator operative to receive as input a current frame and a reference frame from a digital video sequence. The motion estimator may generate and output a motion vector. The motion vector may represent a change in position between a current block of the current frame and a matching reference block of the reference frame. The motion estimator may utilize an enhanced block matching technique to perform block matching based on stationary and spatially proximate blocks. Other embodiments are described and claimed.

    ANTIVIRAL ACYLSULFONAMIDE DERIVATIVES
    9.
    发明申请
    ANTIVIRAL ACYLSULFONAMIDE DERIVATIVES 审中-公开
    抗病毒酰胺酰胺衍生物

    公开(公告)号:US20100135960A1

    公开(公告)日:2010-06-03

    申请号:US12619974

    申请日:2009-11-17

    摘要: The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention relates to novel antiviral compounds represented herein above, pharmaceutical compositions comprising such compounds, and methods for the treatment or prophylaxis of viral (particularly HCV) infection in a subject in need of such therapy with said compounds.

    摘要翻译: 本发明公开了式(I)化合物或其药学上可接受的盐,酯或前药:其抑制含RNA病毒,特别是丙型肝炎病毒(HCV)。 因此,本发明的化合物干扰丙型肝炎病毒的生命周期,也可用作抗病毒剂。 本发明还涉及药物组合物,其包含用于给患有HCV感染的受试者施用的上述化合物。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的HCV感染的方法。 本发明涉及上文所示的新的抗病毒化合物,包含这些化合物的药物组合物,以及用于治疗或预防需要用所述化合物治疗的受试者中的病毒(特别是HCV)感染的方法。

    3,4-BICYCLIC PYRROLIDINE ANTIVIRALS
    10.
    发明申请
    3,4-BICYCLIC PYRROLIDINE ANTIVIRALS 审中-公开
    3,4-双环吡啶类抗生素

    公开(公告)号:US20090326019A1

    公开(公告)日:2009-12-31

    申请号:US12482804

    申请日:2009-06-11

    摘要: The present invention discloses compounds of formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. The present invention relates to novel antiviral compounds represented herein above, pharmaceutical compositions comprising such compounds, and methods for the treatment or prophylaxis of viral (particularly HCV) infection in a subject in need of such therapy with said compounds.

    摘要翻译: 本发明公开了式(I)化合物或其药学上可接受的盐,酯或前药:其抑制含RNA病毒,特别是丙型肝炎病毒(HCV)。 因此,本发明的化合物干扰丙型肝炎病毒的生命周期,也可用作抗病毒剂。 本发明还涉及药物组合物,其包含用于给患有HCV感染的受试者施用的上述化合物。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的HCV感染的方法。 本发明涉及上文所示的新的抗病毒化合物,包含这些化合物的药物组合物,以及用于治疗或预防需要用所述化合物治疗的受试者中的病毒(特别是HCV)感染的方法。